Drugs of abuse in urine
Product Code
PT-DU-FULL-W
Proficiency Testing Scheme
Matrix
Industry Sector/s
Product Format
3 x 15ml lyophilized human urine. Full participants will be able to report for the screening only analytes using immunoassay type techniques and individual analytes by chromatography type techniques. Approximately 210 individual analytes are available and are managed by your PORTAL online screening profile.
Accreditation
ISO/IEC 17043
Product Information
Analyte Data
Analyte Name
Range
Units
Accreditation
(-)-11-Nor-9-carboxy-delta9-THC
-
µg/L
(±)-Methadone
-
µg/L
2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine
-
µg/L
6-Acetylmorphine
-
µg/L
Amfetamine
-
μg/L
Amfetamines screen
-
μg/L
Barbiturates Screen
-
μg/L
Benzodiazepines screen
-
μg/L
Benzoylecgonine
-
μg/L
Buprenorphine and Metabolite Screen
-
μg/L
Buprenorphine or Metabolites
-
μg/L
Cannabinoid Screen
-
μg/L
Cocaine
-
μg/L
Cocaine and Metabolite Screen
-
μg/L
Codeine
-
μg/L
Delta-9-THC-COOH
-
μg/L
Dihydrocodeine
-
μg/L
EDDP Screen
-
μg/L
Hydrocodone
-
μg/L
Hydromorphone
-
μg/L
LSD and Metabolite Screen
-
μg/L
LSD or metabolites
-
μg/L
MDMA/MDA/MDEA
-
μg/L
Methadone Screen
-
μg/L
Methyl-amfetamine
-
μg/L
Morphine (total)
-
μg/L
Opiates screen
-
μg/L
Other amfetamine
-
μg/L
Oxycodone
-
μg/L
Oxymorphone
-
μg/L
Phencyclidine (PCP)
-
µg/L
Phencyclidine Screen
-
μg/L
Propoxyphene and Metabolite Screen
-
μg/L
Propoxyphene or metabolites
-
μg/L
Specific barbiturate
-
μg/L
Specific benzodiazepine
-
μg/L
Full membership = individual analytes by chromatography type techniques and screening only analytes using immunoassay type techniques. For Clinical and EWDTS thresholds, please see the DAU Scheme Description.
For details on the full technical specification of the scheme, please refer to the Scheme Description.